Key projects in development

Diater is working on different lines of R&D in the field of diagnosis, both in vivo and in vitro, and in the treatment of allergic diseases. Notable among them are the following:

Diagnosis of allergies to beta-lactams (DAP®

DAP® is the first means of diagnosing hypersensitivity to beta-lactam antibiotics worldwide. This line of research is steadily adding more products to the pipeline to diagnose drug allergies.

VHC-Core

High-sensitivity serological diagnosis of antibodies against hepatitis C virus (HCV). This provides greater sensitivity than other serological diagnosis tests available at present and will allow a higher percentage of patients infected with HCV to be diagnosed.

 

 

Purified allergens for diagnosis and treatment.

Alt a 1 is the first purified major allergen from the fungus Alternaria alternata. It recognises more than 90% of the specific immunoglobulins E from the fungus. This technique for purifying major allergens is being developed for other allergens. Using purified major allergens in their native form increases the sensitivity and specificity of diagnosis, as well as the efficacy and safety of specific immunotherapy, compared to the complete allergen extract from the fungus.

New treatments for respiratory allergic diseases.

To make more convenient and effective treatments available to physicians and patients, at present, Diater is working on a line of research to study new forms of administration and new, safer and more effective types of extract that could reduce the current number of doses and duration of treatment for greater patient convenience.

NOTE!

This website uses proprietary and third-party cookies to enhance our services and study our users browsing habits. If you continue browsing, it will be considered that you have accepted their use. You can change your cookie settings or obtain further information by going to our Cookies Policy. Learn more

I understand

CONTACT US FILLING THE FORM

We hereby inform you that the personal data submitted by you shall be processed by GRUPO FERRER INTERNACIONAL S.A., whose registered address is at Av. Diagonal 549, 5ª planta, 08029, Barcelona (Spain), so that it may maintain and handle its relations with you, as well as to respond to any queries you may submit to us. 

Your personal data shall be stored for 1 year since you submitted your first query.

All personal data processed is based on you having given your consent to do so. You are reminded that you may withdraw your consent at any time.

You may exercise your rights of access, rectification, erasure, restriction of processing, portability of data, as well as to submit any queries or suggestions in respect of the processing of personal data by writing to the Data Protection Officer using any of the following means, along with a copy of your ID document or other means of identification:

(i) By email to lopd@ferrer.com.

(ii) By post addressed to GRUPO FERRER INTERNACIONAL S.A. Av. Diagonal nº 549, 5ª planta, 08029, Barcelona.

You are entitled to submit complaints to the Spanish Data Protection Agency (AEPD), the competent authority on data protection matters by writing a letter to its central offices.

Link to the privacy policy

security image

CONTACT US

914 96 60 13
This email address is being protected from spambots. You need JavaScript enabled to view it.
Share This
Follow Us